Hester Biosciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 77.73 | 64.13 | 74.85 |
| Operating Expense | 62.97 | 53.81 | 58.77 |
| Net Profit | 9.64 | 4.44 | 9.34 |
| Net Profit Margin | 12.40 | 6.92 | 12.48 |
| Earning Per Share | 11.33 | 5.22 | 10.97 |
| EBIDTA | 16.59 | 9.93 | 16 |
| Effective Tax Rate | 24.86 | 16.09 | 19.09 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 77.73 |
| Operating Expense | 62.97 |
| Net Profit | 9.64 |
| Net Profit Margin | 12.40 |
| Earning Per Share | 11.33 |
| EBIDTA | 16.59 |
| Effective Tax Rate | 24.86 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 286.47 | 285.16 | 254 |
| Operating Expenses Annual | 235.52 | 237.81 | 199.11 |
| Operating Profit Annual | 55.71 | 51.60 | 60.21 |
| Interest Annual | 5.37 | 5.09 | 6.50 |
| Depreciation | 8.58 | 9.78 | 9.79 |
| Net Profit Annual | 31.84 | 27.16 | 32.34 |
| Tax Annual | 9.92 | 9.57 | 11.58 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 286.47 |
| Operating Expenses Annual | 235.52 |
| Operating Profit Annual | 55.71 |
| Interest Annual | 5.37 |
| Depreciation | 8.58 |
| Net Profit Annual | 31.84 |
| Tax Annual | 9.92 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.97 | 3.81 | 1.53 |
| Cash Flow from Operations | 63.97 | 42.86 | 33.36 |
| Cash Flow from Investing | -19.04 | -20.59 | -71.96 |
| Cash Flow from Financing | -46.35 | -24.12 | 41.38 |
| Cash Flow at the End | 0.55 | 1.97 | 4.30 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 1.97 |
| Cash Flow from Operations | 63.97 |
| Cash Flow from Investing | -19.04 |
| Cash Flow from Financing | -46.35 |
| Cash Flow at the End | 0.55 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 19.45 | 18.10 | 23.70 |
| PBIT Margin (%) | 16.45 | 14.67 | 19.85 |
| PBT Margin (%) | 13.39 | 11.79 | 16.79 |
| Net PROFIT Margin (%) | 11.11 | 9.52 | 12.73 |
| Return On Networth / Equity (%) | 9.77 | 8.98 | 11.53 |
| Return On Networth /Employed (%) | 9.47 | 8.51 | 11.52 |
| Return On Assets (%) | 6.45 | 5.52 | 7.38 |
| Total Debt / Equity (X) | 0.36 | 0.49 | 0.51 |
| Asset Turnover Ratio (%) | 0.58 | 0.58 | 0.58 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 19.45 |
| PBIT Margin (%) | 16.45 |
| PBT Margin (%) | 13.39 |
| Net PROFIT Margin (%) | 11.11 |
| Return On Networth / Equity (%) | 9.77 |
| Return On Networth /Employed (%) | 9.47 |
| Return On Assets (%) | 6.45 |
| Total Debt / Equity (X) | 0.36 |
| Asset Turnover Ratio (%) | 0.58 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 111.49 | 106.75 | 110.69 |
| Total Current Assets Annual | 185.24 | 204.41 | 216.05 |
| Non Current Assets Annual | 360.76 | 345.13 | 329.77 |
| Total Shareholders Funds Annual | 339.09 | 312.71 | 292.38 |
| Total Assets Annual | 546.00 | 549.55 | 545.82 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 111.49 |
| Total Current Assets Annual | 185.24 |
| Non Current Assets Annual | 360.76 |
| Total Shareholders Funds Annual | 339.09 |
| Total Assets Annual | 546.00 |
EPS (INR)
Expected
1.52
Reported
1.82
Surprise
19.74%
Dec 2024
EPS beaten by 19.74%
Sep 2024
EPS beaten by -2.12%
Jun 2024
EPS beaten by 2.28%
